Objective-Modified lipoproteins, particularly oxidized LDLs, are believed to evoke an inflammatory response which participates in all stages of atherosclerosis. Disposal of these particles is mediated through receptors which may trigger proinflammatory signaling pathways leading to vascular injury. This study was aimed at assessing the role in atherogenesis of one of these receptors, galectin-3. Methods and Results-Galectin-3deficient and wild-type mice were fed an atherogenic diet or standard chow for 8 months. Lesion area and length were higher in galectin-3-deficient versus wild-type mice. At the level of the aortic sinus, wild-type animals showed only fatty streaks, whereas galectin-3-deficient mice developed complex lesions, associated with extensive inflammatory changes. This was indicated by the presence of T lymphocytes with activated Th1-phenotype and by more marked monocyte-macrophage infiltration, inflammatory mediator expression, vascular cell apoptosis, and proinflammatory transcription factor activation. Increased accumulation of oxidixed LDLs and lipoxidation products and upregulation of other receptors for these compounds, including the proinflammatory RAGE, were detected in galectin-3-deficient versus wild-type mice. Conclusions-These data suggest a unique protective role for galectin-3 in the uptake and effective removal of modified lipoproteins, with concurrent downregulation of proinflammatory pathways responsible for atherosclerosis initiation and progression. (Arterioscler Thromb Vasc Biol. 2009;29:831-836.)
A therosclerosis has been increasingly emerged as an inflammatory disease characterized by both systemic and local low-grade inflammation, which is involved in all stages of its natural history, from initiation through progression and, ultimately, the thrombotic complications. 1 Hyperlipidemia contributes to inflammation by causing retention of lipoproteins within the vessel wall, which favors oxidation of their lipid and protein moieties. Lipid endoperoxides resulting from oxidation of unsaturated lipids are further metabolized to reactive carbonyl species, such as acrolein, malondialdehyde, 4-hydroxy-2-nonenal (HNE), 4-hydroxy-2-hexanal and glyoxal, which react with proteins to generate labile or stable adducts or crosslinks called advanced lipoxidation endproducts (ALEs). 2 Oxidation-specific epitopes generated by these reactions constitute a prominent set of pathogen-associated molecular patterns common on multiple endogenous and exogenous structures, which are recognized by pattern recognition receptors (PRRs) of innate immunity on macrophages. 3 The endocytic PRRs, such as the scavenger receptors (SRs), internalize lipoprotein particles, thus causing foam cell formation, whereas the signaling PRRs, such as the toll-like receptors (TLRs), initiate a signal cascade leading to macrophage activation. 1 The classical advanced glycation endproduct (AGE) receptors, such as galectin-3 and the receptor for AGEs (RAGE), share with PRRs the ability of binding modified lipoproteins and ALEs. 4 Indeed, galectin-3 might act as a PRR, 5 by mediating internalization of these compounds, 6 and recent evidence suggests convergence and amplification of TLR and RAGE signaling pathways. 7 Both TLRs 8 and RAGE 9 were found to promote experimental atherogenesis. In contrast, SR-BI was demonstrated to exert a defensive function by promoting cholesterol efflux and transfer to HDLs. Conversely, the definitive role of SR-A1/II and CD36 in atherogenesis is still debated. 10 As other PRRs, galectin-3 is a multifunctional molecule, because it participates also in the regulation of cell proliferation and death, mRNA splicing and cell-to-matrix interaction as well as in the modulation of inflammatory/immune response. 11 We have previously shown that galectin-3 ablation accelerates glomerulopathy induced by diabetes, 12 AGEs, 13 and aging. 14 This was associated with increased AGE levels and altered expression of the other AGE receptors, thus suggesting a protective role of galectin-3 toward AGE-induced injury. Moreover, galectin-3 was induced in proliferating vascular smooth muscle cells (VSMCs) and, particularly, foam cells from experimental animal models of atherogenesis and human subjects with advanced atherosclerotic lesions. [15] [16] [17] This study was aimed at verifying the hypothesis that galectin-3 ablation accelerates experimental atherogenesis and that this effect is mediated predominantly via 2 mechanisms, ie, an impaired uptake of modified lipoproteins and ALEs and a facilitated removal of these compounds via proinflammatory pathways. To show up the accelerating effect of galectin-3 deficiency, we used mice lacking galectin-3 (Lgals3 Ϫ/Ϫ ) on a C57BL/6J background, which is quite resilient to plaque formation, instead of atherosclerosisprone strains such as ApoE-null mice.
Materials and Methods

Design
Adult (aged 3 months) female Lgals3 Ϫ/Ϫ mice (D. Hsu, F.-T. Liu, Department of Dermatology, University of California Davis School of Medicine, Sacramento, CA), generated by gene ablation, 18 and the corresponding C57BL/6J wild-type (WT) mice were fed for 8 months with a Paigen atherogenic high-fat diet (HFD, Mucedola; nϭ23 per group), containing 15% fat, 1.25% cholesterol, and 0.5% Na-cholate, 19 or a standard normal-fat diet (NFD, Charles River Italia; nϭ20 per group), containing 4% fat. The animals were housed and cared in accordance with the Principles of Laboratory Animal Care (NIH Publication no. 85-23, revised 1985) and received water and food at libitum. At the end of the 8-month period, body weights were recorded, then mice were anesthetized with intraperitoneal ketamine (Imalgene, 60 mg/kg body weight) and xylazine (Rompum, 7.5 mg/kg body weight), a blood specimen was obtained, and the heart with attached aorta was sampled. In selected mice, termination was preceded by (1) measurement of blood pressure (BP) by intraarterial catheterization by using a high-fidelity transducer tipped catheter (1.4F, Millar); or (2) assessment of glucose tolerance and insulin sensitivity by intraperitoneal glucose tolerance test (IPGTT, 2 g glucose/kg body weight) and intraperitoneal insulin tolerance test (IPITT, 0.75 UI insulin/kg body weight), respectively.
Aortic Morphology/Morphometry
For the assessment of atherosclerotic lesions, 20 10-m-thick sections obtained from the aortic sinus (ie, the aortic portion alongside the valves) were stained with hematoxylin and eosin for histological analysis and with the Weigert-van Gieson method for elastic and collagen fibers for measurement of lesion area and length with a computer-assisted image analysis system (Optimas 6.5, Bioscan). Lesion analysis was performed on every other section throughout the sinus, and every fifth section along the ascending aorta, nearly up to the aortic arch (800 m from the aortic sinus). Descending aorta was stained with Oil red O for the assessment of lipid accumulation.
Biochemistry
Blood glucose was measured with the aid of an automated colorimetric instrument (Glucocard G meter, Menarini), and serum cho-lesterol and triglycerides by standard chemical methods (VITROS 5,1 FS Chemistry System, Ortho-Clinical Diagnostics).
ELISA
Serum levels of insulin, adiponectin, and isoprostane 8-epi-prostaglandin (PG) F 2␣ were assessed using ELISA kits from Mercodia AB, LINCO Research, and Cayman, respectively. Serum ALE/AGE levels were assessed by a competitive ELISA technique, using a mouse monoclonal antibody recognizing also N -carboxymethyllysine (CML). 13, 14 The activation of NFB/p65 was assessed using the Mercury TransFactor kit (BD Biosciences Clontech) on nuclear protein extracts from the aortic root. 14
Immunohistochemistry
Immunohistochemical analysis 13, 14 was performed to assess the aortic content and distribution of (1) markers of murine macrophage activation (F4/80), T lymphocytes (CD3), activated Th1 lymphocytes (CX chemokine receptor 3, CXCR3), VSMCs (␣-smooth muscle actin, ␣-SMA), and apoptotic cells (active caspase-3); (2) the lipoxidation products HNE adducts, CML (which, under these experimental conditions, is believed to originate primarily from lipoxidation-derived glyoxal), and Cu-oxidized LDLs (oxLDLs), and the marker of peroxynitrite formation nitrotyrosine; (3) the AGE receptors and SRs galectin-3, SR-A1, SR-B1, CD36, and RAGE; and (4) the proinflammatory mediators monocyte chemoattractant protein-1 (MCP-1), vascular cell adhesion molecule-1 (VCAM-1), and the inducible cyclo-oxygenase isoform 2 (Cox-2; please see supplemental Table I , available online at http://atvb.ahajournals.org, for primary antibodies). Sections were analyzed using the Optimas 6.5 image analysis system and results were expressed as percentage of lesion area (or section area, when staining was not limited to the lesion). For active caspase-3, data were expressed as number of positive cells per mm 2 of lesion area.
RT-PCR
Total RNA was extracted from the aortic root by the guanidine thiocyanate-phenol-chloroform method using TRIzol Reagent (Invitrogen Italia). The following transcripts were measured by competitive RT-PCR 12-14 : galectin-3, SR-A1, CD36, TLR-2 and 4, MCP-1, matrix metalloproteinase (MMP)-2 and 9; the transcription factors regulating lipid metabolism, peroxisome proliferator-activated receptor-␥ (PPAR␥), and sterol regulatory element binding protein-1c (SREBP-1c); and the rate-limiting enzymes of cholesterol and fatty acid synthesis, hydroxymethylglutaryl (HMG)-CoA reductase, and acetyl-CoA carboxylase (ACC), respectively (please see supplemental Table II for primers). Results were quantified by scanning densitometry using the ImageJ software and expressed as the ratio of each target to ␤-actin mRNA level.
Statistical Analysis
Results are expressed as meanϮSD. Statistical significance was evaluated by 1-way ANOVA followed by the Student-Newman-Keuls test for multiple comparisons. A probability value Ͻ0.05 was considered significant. All statistical tests were performed on raw data.
Results
Metabolic and Hemodynamic Parameters
Body weights and blood glucose levels did not differ among experimental groups. Serum cholesterol and triglycerides increased significantly in HFD-versus NFD-fed mice, with no difference between the 2 genotypes. Biochemical evidence of insulin resistance was detected only in HFD-fed WT mice, showing significantly increased serum insulin and HOMA-IR, decreased adiponectin, a blunted blood glucose surge and fall, respectively, in response to IPGTT and IPITT, and increased 2-hour insulin levels over baseline at IPGTT 
Aortic Morphometry and Morphology
HFD-fed Lgals3 Ϫ/Ϫ mice showed lesions at the level of the aortic sinus which were quantitatively and qualitatively more severe than those detected in the corresponding WT mice. Staining with the Weigert-Van Gieson method revealed more extensive atherosclerotic lesions and collagen deposition in Lgals3 Ϫ/Ϫ than in WT mice fed a HFD; morphometric analysis showed significantly higher lesion area and length in Lgals3 Ϫ/Ϫ than in WT mice ( Figure 1A through 1D). The WT mice fed a HFD developed only initial lesions, ie, fatty streaks ( Figure 1E ), whereas Lgals3 Ϫ/Ϫ mice showed features indicating more complex lesions with different degrees of progression. These features included inflammatory cell adhesion and penetration within the vessel wall, foam cell formation within the intima and invasion of the media, presence of cholesterol clefts, and a unique tendency to form a fibrous cap around a core of lipids and cell debris ( Figure 1F through 1J ).
Galectin-3 Expression
At variance with NFD-fed WT mice, galectin-3 was highly expressed in animals receiving a HFD; gelectin-3 immunoreactivity was detected within fatty streaks, where it colocalized with F4/80-positive cells and acellular regions, and also in some adventitial cells ( Figure 1L through 1O) . Galectin-3 mRNA content was significantly higher in aortic sections from HFD-versus NFD-fed WT mice ( Figure 1P ).
Inflammatory Infiltrate, Tunica Media Involvement, and Apoptosis
A more marked increase in monocyte-macrophage content was found in Lgals3 Ϫ/Ϫ than in WT HFD-fed mice;
Lgals3 Ϫ/Ϫ animals showed also F4/80-positive cells within the tunica media, at variance with WT mice (Figure 2A , 2B, and 2D). Only Lgals3 Ϫ/Ϫ mice showed an intense positivity for CD3 and CXCR3, indicating an extensive infiltration of T lymphocytes expressing a Th1 phenotype (Figure 2E , 2F, 2H, and 2I). Macrophage-rich lesions contained also T lymphocytes ( Figure 2B and 2C) and vice-versa ( Figure 2F and 2G) . In Lgals3 Ϫ/Ϫ , but not WT mice fed a HFD, tunica media appeared thinned as compared with NFD controls, and positivity for ␣-SMA involved also the lesions, particularly the fibrous cap ( Figure 3A through 3D) . Caspase-3-positive cells were more numerous in Lgals3 Ϫ/Ϫ than in WT mice fed a HFD. In Lgals3 Ϫ/Ϫ mice, apoptosing cells were mainly VSMCs, though macrophages and endothelial cells were not spared, whereas macrophages were the only cells undergoing apoptosis in WT animals ( Figure 3E through 3G) .
Lipoxidation Products and Oxidative Stress
Circulating ALE/AGE and isoprostane 8-epi-PGF 2␣ levels were markedly increased in HFD-fed mice, with significantly higher values in Lgals3 Ϫ/Ϫ than in WT mice (please see supplemental Figure IK through 1L). The content of oxLDLs was also higher in Lgals3 Ϫ/Ϫ than in WT mice fed a HFD; oxLDLs were found both intracellularly, in macrophage-derived foam cells, and in the extracellular space ( Figure 3H  through 3J) . Likewise, the aortic content of HNE adducts, CML ( Figure 4A through 4F) , and nitrotyrosine (please see supplemental Figure IIA through IIC) was significantly higher in Lgals3 Ϫ/Ϫ -HFD than in WT-HFD mice.
AGE-Receptor and SR Expression
The protein or mRNA expression of RAGE, TLR-2, CD36 ( Figure 4G through 4N) , SR-A1 and SR-B1, but not TLR-4 (please see supplemental Figure IID through IIK), was higher in Lgals3 Ϫ/Ϫ than in WT mice fed a HFD and, in the case of RAGE and CD36 protein, also in animals fed a standard diet (not shown). 
Inflammatory Markers
The aortic MCP-1, VCAM-1, and Cox-2 protein content and MCP-1, MMP-2, and -9 mRNA levels were higher in Lgals3 Ϫ/Ϫ than in WT mice given an atherogenic diet (please see supplemental Figure IIIA through IIIL). Cox-2 immunoreactivity in HFD-fed mice involved predominantly macrophages (and also VSMCs in Lgals3 Ϫ/Ϫ mice). Cox-2 staining, particularly of endothelial cells, was also higher in Lgals3 Ϫ/Ϫ versus WT mice fed a NFD (not shown). Activation of NFB/ p65 was significantly higher in Lgals3 Ϫ/Ϫ -HFD than in WT-HFD mice (please see supplemental Figure IIIM ).
Lipid Metabolism and Accumulation
On HFD, gene expression for PPAR-␥ increased only in WT mice, whereas SREBP-1 mRNA increased significantly in both genotypes (please see supplemental Figure IIIN and IIIO). HMG-CoA reductase and ACC mRNA levels did not change significantly among experimental groups (not shown). Apart from fatty streaks and the lipid core of complex lesions observed in Lgals3 Ϫ/Ϫ animals, no significant lipid accumulation was detected in the aortas of both genotypes, as assessed by Oil red O staining (not shown).
Discussion
This study showed that galectin-3 ablation in mice results in accelerated diet-induced atherogenesis, as indicated by the increased extent and particularly complexity of lesions, with development of fibrous cap atheromas in the aortic sinus, in the absence of genetic abnormalities of lipid metabolism.
Though, as expected, true plaque rupture was not observed in Lgals3 Ϫ/Ϫ mice, several features suggestive of plaque progression were detected in these animals. The most striking finding was the extensive infiltration of T lymphocytes expressing a Th1-phenotype, observed uniquely in HFD-fed Lgals3 Ϫ/Ϫ mice. In fact, recruitment of lymphocytes and antigen-presenting cells to the atheroma has been recognized as a critical event in the transition from a stable to a vulnerable plaque. Moreover, a major role has been attributed to Th-1 effector cells and cytokines, 21 which have been shown to predominate in both human 22 and animal 23 lesions. The higher number of cells of the monocyte-macrophage lineage detected in HFD-fed Lgals3 Ϫ/Ϫ versus WT mice might also be relevant, in view of the pivotal role of these cells as bridge between innate and adaptive immune response and source of lipid/necrotic material, proteases and proinflammatory mediators. 1 In fact, Lgals3 Ϫ/Ϫ mice showed a higher expression of these mediators, including VCAM-1, MCP-1, Cox-2, MMP-2, and -9 and a more marked activation of NF-B. The latter was associated with lack of activation of PPAR-␥, which, in addition to regulating metabolism, is involved in transrepression of several inflammatory genes. 24 Moreover, Cox-2 was expressed predominantly in macrophages. At this level, it was shown to be elicited via RAGE/NFB-dependent pathways and to result in the production of proinflammatory PGE 2 inducing the expression of matrix MMP-2 and 9, which favor lesion expansion and plaque rupture. 25 The increased rate of macrophage and VSMC apoptosis detected in HFD-fed Lgals3 Ϫ/Ϫ mice might also be relevant in this regard. In fact, macrophage depletion was shown to promote plaque stability in the early but not later stages of lesion development, whereas VSMC loss contributes to plaque destabilization and rupture, because these cells are responsible for collagen production required to maintain tensile strength. 26 The finding that galectin-3 was upregulated in fatty streaks of mice fed a HFD, together with previous observations showing a predominant or exclusive expression of this molecule in unstable regions of human atherosclerotic plaques, 16, 17 points to a role for galectin-3 in the development of atherosclerotic lesions. The accelerated atherogenesis observed in galectin-3-deficient animals fed a HFD suggests that galectin-3 plays a relevant protective role under these experimental conditions. This is in keeping with our previous studies showing an acceleration of renal injury induced by diabetes, AGEs, and aging in Lgals3 Ϫ/Ϫ mice, [12] [13] [14] but it is in contrast with a recent report showing that C57BL/6J-ApoE null mice on standard diet develop attenuated atherosclerosis when crossbred with Lgals3 Ϫ/Ϫ mice. 27 However, in this report, Lgals3 Ϫ/Ϫ mice were on a 129 genetic background, known to be less prone to develop atherosclerotic lesions than the C57BL/6J background, 28 and the use of the F2 generation raises the possibility that some animals might have been homozygous for susceptibility genes. Moreover, difference in lesion number, but not size, was detected only at the oldest age examined, when the number of animals was small.
Fat accumulation within the aorta was negligible, and levels of circulating lipids and changes in lipid metabolism were similar in the 2 genotypes (with even a lower level of insulin resistance in Lgals3 Ϫ/Ϫ versus WT mice), thus not accounting for differences in lesion extent and complexity. Instead, protection could be mediated through mechanisms involving (1) ALE/AGE receptor and SR function and (2) and immunomodulatory actions of galectin-3.
Firstly, accelerated atherogenesis was associated with increased carbonyl and oxidative stress and ALE/AGE receptor and SR expression, thus indicating that the lack of galectin-3 is associated with (1) reduced ALE/AGE removal or (2) enhanced disposal of these products through RAGE and possibly other proinflammatory and prooxidant receptors such as TLR-2. This implies that galectin-3 is predominantly involved in ALE/AGE removal, with parallel downregulation of RAGE-dependent ALE/AGE uptake and downstream events, including signaling through intracellular proinflammatory pathways leading to oxidant-dependent tissue injury.
Secondly, in addition to downregulating RAGE-dependent proinflammatory pathways, galectin-3 is known to serve as both positive and negative regulator of inflammatory response, depending on specific inflammatory conditions, type of targeted cell, or galectin-3 expression level. 11 Galectin-3 was in fact shown to exert several proinflammatory actions, including (1) triggering of respiratory burst in neutrophils and monocytes; (2) induction of inflammatory mediator release by mast cells; (3) promotion of adhesion of neutrophils to laminin and endothelial cells; and (4) chemoattraction of monocytes and macrophages. 11 Studies in galectin-3-deficient mice with experimentally-induced peritonitis have provided strong evidence of its proinflammatory effects. 18 However, other reports have indicated that galectin-3 promotes apoptosis 29 and reduces TCR-mediated signaling in T cells, 30 thus exerting a relevant antiinflammatory function which might explain the extensive T lymphocyte infiltration and activation observed in our HFD-fed Lgals3 Ϫ/Ϫ animals. Moreover, galectin-3 was found to promote phagocytic function 31 and its deficiency could have impaired phagocytosis of apoptotic cells, leading to secondary necrosis and consequent proinflammatory response. 32 This defective phagocytosis might have been aggravated by the enhanced accumulation of oxLDLs within the lesions of Lgals3 Ϫ/Ϫ mice, in keeping with previous observations showing that oxidized molecules inhibit the uptake of apoptotic cells by phagocytes via several mechanisms, including competitive receptor inhibition. 32 The detection of oxLDLs in the extracellular space seems to support this view. Finally, galectin-3 was shown to drive alternative macrophage activation, 33 and lack of galectin-3 could have inhibited the resolution of inflammation driven by alternatively activated (M2-polarized) macrophages.
In conclusion, these data show that galectin-3 ablation results in accelerated atherogenesis associated with increased ALE accumulation, oxidative stress, inflammation, and activation of the innate and adaptive immune system. These data suggest a unique role for galectin-3 in the uptake and effective removal of modified lipoproteins as well as in the modulation of the inflammatory response. Under conditions of enhanced carbonyl and oxidative stress, such as lipid-induced atherogenesis, galectin-3 appears to downregulate RAGE-dependent proinflammatory pathways and to exert direct antiinflammatory functions on infiltrating macrophages and lymphocytes.
